BACKGROUND: The role of implant surface properties for bone formation and bone remodeling, that is, the major events during osseointegration, are incompletely understood. PURPOSE: This experimental study aimed to investigate the relation between molecular and morphological patterns at the bone interface for machined and oxidized implants. MATERIALS AND METHODS: Machined and anodically oxidized titanium implants were inserted in rat tibiae. The implants and surrounding tissue were retrieved at 1, 3, 6, 14, or 28 days for gene expression, histology, histomorphometry, backscatter scanning electron microscopy, and transmission electron microscopy. RESULTS: Compared with machined-surface implants, a higher degree of mineralized bone was found in contact with the oxidized-surface implants. After 3 days, cells adherent to the oxidized implants demonstrated a markedly higher expression of receptor activator of nuclear factor kappa-B (RANK), receptor activator of nuclear factor kappa-B ligand (RANKL), and osteoprotegerin (OPG). Whereas the OPG expression was higher at the machined implants at 6, 14, and 28 days, a higher RANKL/OPG ratio was detected at the oxidized implants. Between 3 and 14 days, both implants demonstrated a temporal increase in RANKL/OPG, corresponding to the remodeling phase at the bone-implant interface. For both implant types, the RANKL/OPG ratio sharply decreased to a low level after 28 days. CONCLUSIONS: The present results show that oxidized implants rapidly promote a high degree of mineralized bone apposition to the surface. As determined by the gene expression data, the mechanisms involve an early induction of osteoclastic differentiation and subsequently more intensive bone remodeling, which accelerates the maturation of the bone-implant interface. The present study suggests that the RANKL/OPG ratio is a sensitive indicator for monitoring the remodeling process during osseointegration.
BACKGROUND: The role of implant surface properties for bone formation and bone remodeling, that is, the major events during osseointegration, are incompletely understood. PURPOSE: This experimental study aimed to investigate the relation between molecular and morphological patterns at the bone interface for machined and oxidized implants. MATERIALS AND METHODS: Machined and anodically oxidized titanium implants were inserted in rat tibiae. The implants and surrounding tissue were retrieved at 1, 3, 6, 14, or 28 days for gene expression, histology, histomorphometry, backscatter scanning electron microscopy, and transmission electron microscopy. RESULTS: Compared with machined-surface implants, a higher degree of mineralized bone was found in contact with the oxidized-surface implants. After 3 days, cells adherent to the oxidized implants demonstrated a markedly higher expression of receptor activator of nuclear factor kappa-B (RANK), receptor activator of nuclear factor kappa-B ligand (RANKL), and osteoprotegerin (OPG). Whereas the OPG expression was higher at the machined implants at 6, 14, and 28 days, a higher RANKL/OPG ratio was detected at the oxidized implants. Between 3 and 14 days, both implants demonstrated a temporal increase in RANKL/OPG, corresponding to the remodeling phase at the bone-implant interface. For both implant types, the RANKL/OPG ratio sharply decreased to a low level after 28 days. CONCLUSIONS: The present results show that oxidized implants rapidly promote a high degree of mineralized bone apposition to the surface. As determined by the gene expression data, the mechanisms involve an early induction of osteoclastic differentiation and subsequently more intensive bone remodeling, which accelerates the maturation of the bone-implant interface. The present study suggests that the RANKL/OPG ratio is a sensitive indicator for monitoring the remodeling process during osseointegration.
Authors: Sheng Zhu; Victor Häussling; Romina H Aspera-Werz; Tao Chen; Bianca Braun; Weidong Weng; Tina Histing; Andreas K Nussler Journal: Int J Mol Sci Date: 2020-12-23 Impact factor: 5.923
Authors: Dimitrios Karazisis; Ahmed M Ballo; Sarunas Petronis; Hossein Agheli; Lena Emanuelsson; Peter Thomsen; Omar Omar Journal: Int J Nanomedicine Date: 2016-04-01
Authors: Furqan A Shah; Martin L Johansson; Omar Omar; Hanna Simonsson; Anders Palmquist; Peter Thomsen Journal: PLoS One Date: 2016-06-14 Impact factor: 3.240
Authors: Furqan A Shah; Patrik Stenlund; Anna Martinelli; Peter Thomsen; Anders Palmquist Journal: J Mater Sci Mater Med Date: 2016-10-03 Impact factor: 3.896
Authors: Kohei Murase; Patrik Stenlund; Peter Thomsen; Jukka Lausmaa; Anders Palmquist Journal: J Mater Sci Mater Med Date: 2018-06-30 Impact factor: 3.896